These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 16988266)

  • 21. The detection of protective antigen (PA) associated with spores of Bacillus anthracis and the effects of anti-PA antibodies on spore germination and macrophage interactions.
    Cote CK; Rossi CA; Kang AS; Morrow PR; Lee JS; Welkos SL
    Microb Pathog; 2005; 38(5-6):209-25. PubMed ID: 15925272
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Ratio of lethal and edema factors in rabbit systemic anthrax.
    Molin FD; Fasanella A; Simonato M; Garofolo G; Montecucco C; Tonello F
    Toxicon; 2008 Dec; 52(7):824-8. PubMed ID: 18812184
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Protein- and DNA-based anthrax toxin vaccines confer protection in guinea pigs against inhalational challenge with Bacillus cereus G9241.
    Palmer J; Bell M; Darko C; Barnewall R; Keane-Myers A
    Pathog Dis; 2014 Nov; 72(2):138-42. PubMed ID: 25044336
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Development of an inhalational Bacillus anthracis exposure therapeutic model in cynomolgus macaques.
    Henning LN; Comer JE; Stark GV; Ray BD; Tordoff KP; Knostman KA; Meister GT
    Clin Vaccine Immunol; 2012 Nov; 19(11):1765-75. PubMed ID: 22956657
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Development of a simple method for the rapid identification of organisms causing anthrax by coagglutination test.
    Sumithra TG; Chaturvedi VK; Gupta PK; Siju SJ; Susan C; Bincy J; Laxmi U; Sunita SC; Rai AK
    Biologicals; 2014 Nov; 42(6):316-21. PubMed ID: 25151655
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Development of a simple and rapid method for the specific identification of organism causing anthrax by slide latex agglutination.
    Sumithra TG; Chaturvedi VK; Gupta PK; Sunita SC; Rai AK; Kutty MV; Laxmi U; Murugan MS
    Lett Appl Microbiol; 2014 May; 58(5):401-7. PubMed ID: 24286182
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Immunization with a Recombinant, Pseudomonas fluorescens-Expressed, Mutant Form of Bacillus anthracis-Derived Protective Antigen Protects Rabbits from Anthrax Infection.
    Reed MD; Wilder JA; Mega WM; Hutt JA; Kuehl PJ; Valderas MW; Chew LL; Liang BC; Squires CH
    PLoS One; 2015; 10(7):e0130952. PubMed ID: 26207820
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Contribution of immunological memory to protective immunity conferred by a Bacillus anthracis protective antigen-based vaccine.
    Marcus H; Danieli R; Epstein E; Velan B; Shafferman A; Reuveny S
    Infect Immun; 2004 Jun; 72(6):3471-7. PubMed ID: 15155654
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Search for correlates of protective immunity conferred by anthrax vaccine.
    Reuveny S; White MD; Adar YY; Kafri Y; Altboum Z; Gozes Y; Kobiler D; Shafferman A; Velan B
    Infect Immun; 2001 May; 69(5):2888-93. PubMed ID: 11292703
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Characterization of a therapeutic model of inhalational anthrax using an increase in body temperature in New Zealand white rabbits as a trigger for treatment.
    Comer JE; Ray BD; Henning LN; Stark GV; Barnewall RE; Mott JM; Meister GT
    Clin Vaccine Immunol; 2012 Sep; 19(9):1517-25. PubMed ID: 22837095
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Comparative evaluation of protective antigen produced from Bacillus anthracis & Escherichia coli.
    Sastry KS; Tuteja U; Bala Krishna K; Batra HV
    Indian J Med Res; 2003 Mar; 117():111-8. PubMed ID: 14575176
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Efficacy of Single and Combined Antibiotic Treatments of Anthrax in Rabbits.
    Weiss S; Altboum Z; Glinert I; Schlomovitz J; Sittner A; Bar-David E; Kobiler D; Levy H
    Antimicrob Agents Chemother; 2015 Dec; 59(12):7497-503. PubMed ID: 26392505
    [TBL] [Abstract][Full Text] [Related]  

  • 33. mAbs to Bacillus anthracis capsular antigen for immunoprotection in anthrax and detection of antigenemia.
    Kozel TR; Murphy WJ; Brandt S; Blazar BR; Lovchik JA; Thorkildson P; Percival A; Lyons CR
    Proc Natl Acad Sci U S A; 2004 Apr; 101(14):5042-7. PubMed ID: 15051894
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Kinetics of lethal factor and poly-D-glutamic acid antigenemia during inhalation anthrax in rhesus macaques.
    Boyer AE; Quinn CP; Hoffmaster AR; Kozel TR; Saile E; Marston CK; Percival A; Plikaytis BD; Woolfitt AR; Gallegos M; Sabourin P; McWilliams LG; Pirkle JL; Barr JR
    Infect Immun; 2009 Aug; 77(8):3432-41. PubMed ID: 19506008
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A cationic lipid-formulated plasmid DNA vaccine confers sustained antibody-mediated protection against aerosolized anthrax spores.
    Hermanson G; Whitlow V; Parker S; Tonsky K; Rusalov D; Ferrari M; Lalor P; Komai M; Mere R; Bell M; Brenneman K; Mateczun A; Evans T; Kaslow D; Galloway D; Hobart P
    Proc Natl Acad Sci U S A; 2004 Sep; 101(37):13601-6. PubMed ID: 15342913
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Novel and unique diagnostic biomarkers for Bacillus anthracis infection.
    Sela-Abramovich S; Chitlaru T; Gat O; Grosfeld H; Cohen O; Shafferman A
    Appl Environ Microbiol; 2009 Oct; 75(19):6157-67. PubMed ID: 19648366
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Oral administration of a Salmonella enterica-based vaccine expressing Bacillus anthracis protective antigen confers protection against aerosolized B. anthracis.
    Stokes MG; Titball RW; Neeson BN; Galen JE; Walker NJ; Stagg AJ; Jenner DC; Thwaite JE; Nataro JP; Baillie LW; Atkins HS
    Infect Immun; 2007 Apr; 75(4):1827-34. PubMed ID: 17145938
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Immunogenicity of the recombinant Bacillus strains with cloned gene of biosynthesis of protective antigen against Bacillus anthracis].
    Mikshis NI; Kudriavtseva OM; Bolothikova MF; Shulepov DV; Novikova LV; Popov IuA; Shchukovskaia TN; Drozdov IG; Kutyrev VV
    Mol Gen Mikrobiol Virusol; 2007; (3):15-21. PubMed ID: 17886469
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Epitope-focused peptide immunogens in human use adjuvants protect rabbits from experimental inhalation anthrax.
    Oscherwitz J; Feldman D; Yu F; Cease KB
    Vaccine; 2015 Jan; 33(3):430-6. PubMed ID: 25454087
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A recombinant 63-kDa form of Bacillus anthracis protective antigen produced in the yeast Saccharomyces cerevisiae provides protection in rabbit and primate inhalational challenge models of anthrax infection.
    Hepler RW; Kelly R; McNeely TB; Fan H; Losada MC; George HA; Woods A; Cope LD; Bansal A; Cook JC; Zang G; Cohen SL; Wei X; Keller PM; Leffel E; Joyce JG; Pitt L; Schultz LD; Jansen KU; Kurtz M
    Vaccine; 2006 Mar; 24(10):1501-14. PubMed ID: 16271808
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.